Login | Register

FDA Approves Vibativ (Telavancin) For Bacterial Pneumonia

Vibativ (telavancin) has been approved by the FDA to treat HABP/VABP (hospital-acquired ventilator-associated bacterial pneumonia) caused by Staphylococcus aureus. The FDA (Food and Drug Administration) added that telavancin should only be used when other treatments are not appropriate...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *